PF-03446962
A8471005
Phase 2 small_molecule terminated
Quick answer
PF-03446962 for Carcinoma, Hepatocellular is a Phase 2 program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer
- Indication
- Carcinoma, Hepatocellular
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated